Cargando…

Identification of In Vitro Inhibitors of Monkeypox Replication

Monkeypox virus (MPXV) infections in humans have historically been restricted to regions of endemicity in Africa. However, in 2022, an alarming number of MPXV cases were reported globally, with evidence of person-to-person transmission. Because of this, the World Health Organization (WHO) declared t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiem, Kevin, Nogales, Aitor, Lorenzo, Maria, Morales Vasquez, Desarey, Xiang, Yan, Gupta, Yogesh K., Blasco, Rafael, de la Torre, Juan Carlos, Martínez-Sobrido, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434227/ https://www.ncbi.nlm.nih.gov/pubmed/37278625 http://dx.doi.org/10.1128/spectrum.04745-22

Ejemplares similares

Identification of Inhibitors of ZIKV Replication
por: Morales Vasquez, Desarey, et al.
Publicado: (2020)

Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development
por: Lorenzo, María M., et al.
Publicado: (2022)

Bi-Reporter Vaccinia Virus for Tracking Viral Infections In Vitro and In Vivo
por: Chiem, Kevin, et al.
Publicado: (2021)

Amino Acid Residues Involved in Inhibition of Host Gene Expression by Influenza A/Brevig Mission/1/1918 PA-X
por: Chiem, Kevin, et al.
Publicado: (2021)

Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine
por: Hilimire, Thomas A., et al.
Publicado: (2020)

A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening
por: Gorshkov, Kirill, et al.
Publicado: (2021)

SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening
por: Gorshkov, Kirill, et al.
Publicado: (2022)

In vivo rescue of recombinant Zika virus from an infectious cDNA clone and its implications in vaccine development
por: Ávila-Pérez, Gines, et al.
Publicado: (2020)

Generation and Characterization of Recombinant SARS-CoV-2 Expressing Reporter Genes
por: Chiem, Kevin, et al.
Publicado: (2021)

Replication-Competent Influenza A Viruses Expressing Reporter Genes
por: Breen, Michael, et al.
Publicado: (2016)

Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies
por: Breen, Michael, et al.
Publicado: (2016)

Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus
por: Chiem, Kevin, et al.
Publicado: (2022)

A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo
por: Chiem, Kevin, et al.
Publicado: (2021)

A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines
por: White, Chantelle L., et al.
Publicado: (2021)

Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins in vitro and in vivo
por: Nogales, Aitor, et al.
Publicado: (2019)

Reverse Genetics Approaches for the Development of Influenza Vaccines
por: Nogales, Aitor, et al.
Publicado: (2016)

Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication
por: Lenartowicz, Elzbieta, et al.
Publicado: (2016)

Interferon-Induced Protein 44 Interacts with Cellular FK506-Binding Protein 5, Negatively Regulates Host Antiviral Responses, and Supports Virus Replication
por: DeDiego, Marta L., et al.
Publicado: (2019)

Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
por: Ye, Chengjin, et al.
Publicado: (2021)

Potent Inhibition of Zika Virus Replication by Aurintricarboxylic Acid
por: Park, Jun-Gyu, et al.
Publicado: (2019)

Mutations Designed by Ensemble Defect to Misfold Conserved RNA Structures of Influenza A Segments 7 and 8 Affect Splicing and Attenuate Viral Replication in Cell Culture
por: Jiang, Tian, et al.
Publicado: (2016)

Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes
por: Nogales, Aitor, et al.
Publicado: (2021)

Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine
por: Martínez-Sobrido, Luis, et al.
Publicado: (2018)

Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses
por: Martínez-Sobrido, Luis, et al.
Publicado: (2016)

Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use
por: Nogales, Aitor, et al.
Publicado: (2022)

Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine
por: Nogales, Aitor, et al.
Publicado: (2022)

Viral replication and infectivity of monkeypox through semen
por: Reda, Abdullah, et al.
Publicado: (2022)

Novel Approaches for The Development of Live Attenuated Influenza Vaccines
por: Blanco-Lobo, Pilar, et al.
Publicado: (2019)

Identification of Amino Acid Residues Responsible for Inhibition of Host Gene Expression by Influenza A H9N2 NS1 Targeting of CPSF30
por: Rodriguez, Laura, et al.
Publicado: (2018)

Reverse Genetic Approaches for the Generation of Recombinant Zika Virus
por: Ávila-Pérez, Ginés, et al.
Publicado: (2018)

Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins
por: Nogales, Aitor, et al.
Publicado: (2018)

CoDe: a web-based tool for codon deoptimization
por: Sharma, Divya, et al.
Publicado: (2023)

Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice
por: Silvas, Jesus A., et al.
Publicado: (2021)

Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2
por: Huang, Wei-Chiao, et al.
Publicado: (2022)

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
por: Lorenzo, María M., et al.
Publicado: (2023)

In vitro and in vivo models for monkeypox
por: Rosa, Rafael Borges, et al.
Publicado: (2022)

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

NS1 Protein Mutation I64T Affects Interferon Responses and Virulence of Circulating H3N2 Human Influenza A Viruses
por: DeDiego, Marta L., et al.
Publicado: (2016)

Development of a novel equine influenza virus live-attenuated vaccine
por: Rodriguez, Laura, et al.
Publicado: (2018)

Inhibition of Monkeypox virus replication by RNA interference
por: Alkhalil, Abdulnaser, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r326age5npdt47om3hflujbdlh